フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Latest addition to Alcon’s intraocular lens (IOL) portfolio expands surgeons’ presbyopia-correcting IOL (PC-IOL) offerings Vivity X-WAVE...
GAMCO Investors, Inc. (NYSE:GBL) (“GAMCO”) announced today that representatives of Associated Capital Group, Inc. (NYSE:AC), its recently...
Magenta Medical, Developer of Novel Heart Failure Therapy, Secures $4 Million in Seed Round from Pitango Venture Capital Magenta Medical...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 (Amendment...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION...
The Zacks Analyst Blog Highlights: Alcon, Novartis AG, Lazard, Celgene and Elan PR Newswire CHICAGO, April 11, 2011 CHICAGO, April 11, 2011...
Registration No. 333-162736 As filed with the Securities and Exchange Commission on April 8, 2011 UNITED...
Registration No. 333-111145 As filed with the Securities and Exchange Commission on April 8, 2011 UNITED STATES SECURITIES AND...
Registration No. 333-100746 As filed with the Securities and Exchange Commission on April 8, 2011 UNITED STATES...
Registration No. 333-86882 As filed with the Securities and Exchange Commission on April 8, 2011 UNITED STATES...
Registration No. 333-162738 As filed with the Securities and Exchange Commission on April 8, 2011 UNITED STATES SECURITIES AND...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR...
Alcon, Inc. (NYSE:ACL) announced that its shareholders approved the merger of Alcon into Novartis AG at its Annual General...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約